{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T21:30:07Z","timestamp":1777152607854,"version":"3.51.4"},"reference-count":18,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Abstract is missing (Short communication)<\/jats:p>","DOI":"10.2340\/actadv.v104.40645","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T06:06:40Z","timestamp":1725516400000},"page":"adv40645","source":"Crossref","is-referenced-by-count":1,"title":["Type 2 Diabetes and its Treatment with Linagliptin are both Associated with Elevated Mortality in Bullous Pemphigoid"],"prefix":"10.2340","volume":"104","author":[{"given":"P\u00e4ivi","family":"Leisti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Pankakoski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jari","family":"Jokelainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Huilaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaana","family":"Panelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaisa","family":"Tasanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Outi","family":"Varpuluoma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2024,9,4]]},"reference":[{"key":"72912","doi-asserted-by":"crossref","unstructured":"Tasanen K, Varpuluoma O, Nishie W. Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid. Front Immunol 2019; 10: 1238.","DOI":"10.3389\/fimmu.2019.01238"},{"key":"72913","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3389\/fimmu.2019.01238","DOI":"10.3389\/fimmu.2019.01238"},{"key":"72914","doi-asserted-by":"crossref","unstructured":"Leisti P, Pankakoski A, Jokelainen J, Varpuluoma O, Huilaja L, Panelius J, et al. Accurate diagnosis of bullous pemphigoid requires multiple health care visits. Front Immunol 2023: 27: 14: 1281302.","DOI":"10.3389\/fimmu.2023.1281302"},{"key":"72915","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3389\/fimmu.2023.1281302","DOI":"10.3389\/fimmu.2023.1281302"},{"key":"72916","doi-asserted-by":"crossref","unstructured":"F\u00f6rsti A, Huilaja L, Schmidt E, Tasanen K. Neurological and psychiatric associations in bullous pemphigoid - more than skin deep? Exp Dermatol 2017; 26: 1228-1234.","DOI":"10.1111\/exd.13401"},{"key":"72917","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/exd.13401","DOI":"10.1111\/exd.13401"},{"key":"72918","doi-asserted-by":"crossref","unstructured":"Nieto-Benito LM, Berg\u00f3n-Send\u00edn M, Pulido-P\u00e9rez A, Rosell-D\u00edaz \u00c1M, Parra-Blanco V, Su\u00e1rez-Fern\u00e1ndez R. Defining dipeptidyl peptidase-4 inhibitors-related bullous pemphigoid: a single-centre retrospective study. Exp Dermatol 2021; 30: 1345-1351.","DOI":"10.1111\/exd.14387"},{"key":"72919","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/exd.14387","DOI":"10.1111\/exd.14387"},{"key":"72920","doi-asserted-by":"crossref","unstructured":"Kiny\u00f3 \u00c1, Hanyecz A, Lengyel Z, V\u00e1rszegi D, Ol\u00e1h P, Gy\u00f6m\u00f6rei C, et al. Clinical, laboratory and histological features of dipeptidyl peptidase-4 inhibitor related noninflammatory bullous pemphigoid. J Clin Med 2021; 10: 1916.","DOI":"10.3390\/jcm10091916"},{"key":"72921","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3390\/jcm10091916","DOI":"10.3390\/jcm10091916"},{"key":"72922","doi-asserted-by":"crossref","unstructured":"Horikawa H, Kurihara Y, Funakoshi T, Umegaki-Arao N, Takahashi H, Kubo A, et al. Unique clinical and serological features of bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors. Br J Dermatol 2018; 6: 1462-1463.","DOI":"10.1111\/bjd.16479"},{"key":"72923","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.16479","DOI":"10.1111\/bjd.16479"},{"key":"72924","doi-asserted-by":"crossref","unstructured":"Chen X, Zhang Y, Luo Z, Wu Y, Niu T, Zheng J, et al. Prognostic factors for mortality in bullous pemphigoid: a systematic review and meta-analysis. PLoS One 2022. 15; 17: e0264705.","DOI":"10.1371\/journal.pone.0264705"},{"key":"72925","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1371\/journal.pone.0264705","DOI":"10.1371\/journal.pone.0264705"},{"key":"72926","doi-asserted-by":"crossref","unstructured":"Mannucci E, Nreu B, Montereggi C, Ragghianti B, Gallo M, Giaccari A, et al. Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: an extensive meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 2021; 22; 31: 2745-2755.","DOI":"10.1016\/j.numecd.2021.06.002"},{"key":"72927","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.numecd.2021.06.002","DOI":"10.1016\/j.numecd.2021.06.002"},{"key":"72928","doi-asserted-by":"crossref","unstructured":"Kanie T, Mizuno A, Takaoka Y, Suzuki T, Yoneoka D, Nishikawa Y, et al. Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis. Cochrane Database Syst Rev 2021; 10: CD013650.","DOI":"10.1002\/14651858.CD013650.pub2"},{"key":"72929","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/14651858.CD013650.pub2","DOI":"10.1002\/14651858.CD013650.pub2"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/40645\/47573","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/40645\/47573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T06:06:53Z","timestamp":1725516413000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/40645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":18,"URL":"https:\/\/doi.org\/10.2340\/actadv.v104.40645","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,4]]}}}